Armistice Capital, LLC Citius Pharmaceuticals, Inc. Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 7,276,000 shares of CTXR stock, worth $1.24 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,276,000
Previous 10,156,000
28.36%
Holding current value
$1.24 Million
Previous $5.89 Million
38.23%
% of portfolio
0.06%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding CTXR
# of Institutions
60Shares Held
23.5MCall Options Held
83.1KPut Options Held
32.1K-
Vanguard Group Inc Valley Forge, PA6.44MShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$319,4220.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$306,9730.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$196,9460.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ932KShares$158,4110.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $24.8M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...